Dexmedetomidine in Obturator Nerve Block as an Analgesic in Transurethral Surgeries

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

July 20, 2024

Study Completion Date

August 1, 2024

Conditions
Dexmedetomidine
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine (DEX), an α2-agonist with more promising pharmacokinetic and pharmacodynamic characteristics than clonidine has been proved to have a positive effect on postoperative pain intensity and to reduce opioid consumption

DRUG

Bupivacaine Hydrochloride

local anesthesic which works through blocking sodium channels

Trial Locations (1)

11562

Faculty of Medicine-Cairo Univeristy, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT06229054 - Dexmedetomidine in Obturator Nerve Block as an Analgesic in Transurethral Surgeries | Biotech Hunter | Biotech Hunter